Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

Penel, N; Demetri, G D; Blay, J Y; Cousin, S; Maki, R G; Chawla, S P; Judson, I; von Mehren, M; Schöffski, P; Verweij, J

doi:10.1093/annonc/mds470

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

NobleIDNI7P62W77R99S83

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A11CDD45.svg?ark=w1%2F20260515%2FA11CDD45&value=id)](https://nobleid.org/work/w1/20260515/A11CDD45)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

NobleIDNI7P62W77R99S83

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A11CDD45.svg?ark=w1%2F20260515%2FA11CDD45&value=id)](https://nobleid.org/work/w1/20260515/A11CDD45)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work